Stem cell spe­cial­ist Ncar­dia bags new funds to help scale man­u­fac­tur­ing ops

A Bel­gian cell ther­a­py com­pa­ny has se­cured $60 mil­lion in fund­ing to strength­en its man­u­fac­tur­ing op­er­a­tions, and grow the cell and gene ther­a­py ecosys­tem across …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER